$VICR

Davies Philip D sold $63K of VICR

Davies Philip D (VP Global Sales & Marketing) sold 200 shares of VICOR CORP (VICR) at $316.26 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Davies Philip D
Published Jun 2, 2026, 2:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 2:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosed open-market sale is executed under a pre-arranged Rule 10b5-1 plan, which generally lowers the likelihood that the trade reflects new, material information.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure is unlikely to drive a fundamental repricing.

03

What to watch

Insider sales can be driven by diversification, taxes, or scheduled liquidity needs; without net buying or additional context, directional inference is weak.

Relevance 6/10Novelty 3/10Timing: Filed today; reflects sale executed 2026-06-01.

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR officer/director sold $63.3K of shares in an open-market transaction under a pre-arranged 10b5-1 plan on 2026-06-01.

Expected impact

Low probability of sustained price impact; any effect is likely short-lived unless accompanied by unusual volume or follow-on disclosures.

Evidence & confidence

The filing is a routine insider transaction with stated 10b5-1 plan usage, which typically reduces interpretability as new negative information.

Market effects

No clear sector read-through from a single disclosed 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Because the sale is pre-arranged, it may be misread as bearish; the more relevant signal would be whether future filings show acceleration or purchases.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • Davies Philip D

    VP Global Sales & Marketing; sold 200 shares on 2026-06-01 under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: